X
Active Filter(s):
Details:
Partnership will support clinical trial studies of BIO 300 in COVID-19 patients.
Lead Product(s): Genistein
Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: BIO 300
Highest Development Status: Phase II Product Type: Small molecule
Partner/Sponsor/Collaborator: Humanetics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership August 19, 2020